跳至主要内容
临床试验/NCT01100099
NCT01100099已完成2 期

HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2006年9月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100
试验地点
2
主要终点
HLA-DQ2-tetramer response after gluten challenge

研究概览

简要总结

The investigators will evaluate the use of an HLA-DQ2-gliadin tetramer for staining of gluten specific T cells in the diagnostics of uncertain celiac disease. Some patients have started on a gluten free diet without a diagnosis of celiac disease. Subsequent later investigation in special care is difficult as the patients often are reluctant to prolonged gluten challenge. The investigators use the HLA-DQ2-gliadin tetramers for detection of gluten specific T cells after a short gluten challenge. By this method the investigators search to discriminate between true celiac disease and clinical gluten intolerance without celiac disease, in a population of HLA-DQ2+ persons already on a gluten free diet without a formal diagnosis of celiac disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HLA-DQ2+ celiacs and HLA-DQ2+ persons who have been on a gluten free diet for at least 4 weeks.

排除标准

  • Other severe disease
  • Refusal to participate
  • HLA-DQ2 negativity

结局指标

主要结局

HLA-DQ2-tetramer response after gluten challenge

时间窗: 6 days.

FACS analysis of peripheral blood after gluten challenge.

次要结局

  • Mucosal responses to 3 day gluten challenge.(4 days.)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验